Amgen Inc. AMGN
478.48 USD +17.22 (+3.73%)
At closeNov 5, 2026, 6:05 AM EST
479.90 +1.42 +0.30%
Pre-market · Nov 5, 6:05 AM ET
464.13 Day range 482.48
302.13 52-week range 482.48
- YTD
- +46.19%
- 1 year
- +49.59%
Analyst view
Consensus: hold
Hold
Price target (mean) 404.32 -15.5% downside
Now 478.48
- Target (low)
- 225.00
- Target (mean)
- 404.32
- Target (high)
- 536.00
Ratings (0m) 34 12 buy · 17 hold · 5 sell
- Strong buy4
- Buy8
- Hold17
- Sell3
- Strong sell2
Recommendation trend
- This month 34
- 1 month ago 34
- 2 months ago 34
- 3 months ago 34
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 5.76 | 5.31 – 6.10 | 5.29 | +8.8% | 10.40B | +5.4% | 22 |
| Next quarter | 5.69 | 5.13 – 6.09 | 5.15 | +10.5% | 9.41B | +9.2% | 10 |
| Current year | 23.21 | 22.94 – 23.96 | 21.84 | +6.3% | 39.29B | +6.9% | 26 |
| Next year | 24.59 | 23.14 – 26.56 | 23.21 | +5.9% | 40.61B | +3.4% | 32 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 4, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Nov 4, 2026 | TD Cowen | Maintained | Buy | Buy |
| Nov 4, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Nov 4, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 4, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 4, 2026 | Truist Securities | Maintained | Hold | Hold |
| Nov 4, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Nov 4, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Oct 23, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 21, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 13, 2026 | Guggenheim | Maintained | Neutral | Neutral |
| Oct 12, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Oct 12, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 9, 2026 | UBS | Maintained | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Oct 7, 2026 | Truist Securities | Maintained | Hold | Hold |
| Oct 7, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Sep 29, 2026 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Sep 10, 2026 | HSBC | Downgrade | Buy | Hold |
| Sep 8, 2026 | BMO Capital | Downgrade | Outperform | Market Perform |
| Sep 8, 2026 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Sep 4, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Aug 20, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 19, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 19, 2026 | Argus Research | Maintained | Buy | Buy |
| Aug 18, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Aug 18, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Aug 14, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 10, 2026 | Guggenheim | Maintained | Neutral | Neutral |
